Article: Complaint Filed With FDA Against RU486.(United States Food and Drug Administration abortion drug)(Evaluation)

A 92-page "Citizen Petition" filed with the Food and Drug Administration is asking the FDA to rescind its approval of RU486, the French abortion pill, because of safety concerns and procedural violations in the drug approval process.

The petition, formally filed on August 20, details numerous ways in which the Clinton-Gore FDA bent or broke its own rules to get the drug on the market just prior to the 2000 election. Now, nearly two years later, the release of government documents has given petitioners and the public at large the opportunity to see just how many times and ways the agency cut corners to satisfy a political constituency and put women's lives and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!